Literature DB >> 33137610

Self-reported cognitive biases in depression: A meta-analysis.

Inés Nieto1, Elena Robles1, Carmelo Vazquez2.   

Abstract

Despite the influence of Beck's cognitive models of depression, the presence and magnitude of the specific proposed cognitive biases have not been systematically investigated. After a systematic search in PsycInfo and PubMED, studies reporting self-reported outcomes on cognitive biases and depressive symptoms in depressed and/or healthy groups were included. From a total of 4840 records, two different meta-analyses were conducted. 23 studies on 4865 participants provided data about catastrophising and depression (g = 0.95, 95% CI [0.64; 1.26]) and 40 studies on 4678 participants provided data about interpretation bias in depression (g = 0.78, 95% CI [0.43; 1.13]). Moderation analyses showed that the relationship between catastrophising and depression was higher in studies with more women, when the corresponding author was from a Western country, and when the instrument to measure depression was the DSM criteria, the SCL-90, the BDI, or the DASS. The relationship between interpretation bias and depressive symptoms was significant only in studies comparing depressed and healthy groups, and when using specific instruments to measure symptoms (DSM/RDC criteria plus a scale cut-off score) and cognitive bias (CDQ/CBQ, SCT, AST-D, other). Some limitations are acknowledged, but risk of publication bias was found to be low, and these results support the utility of some self-reported measures of cognitive biases in depression.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Catastrophizing; Cognitive bias; Cognitive model; Depression; Interpretation bias

Year:  2020        PMID: 33137610     DOI: 10.1016/j.cpr.2020.101934

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  1 in total

1.  'Relearning how to think': A brief online intervention to modify biased interpretations in emotional disorders-study protocol for a randomised controlled trial.

Authors:  Inés Nieto; Carmelo Vazquez
Journal:  Trials       Date:  2021-07-31       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.